Wooyang P&L Co.,Ltd. (KRX:002420)
South Korea · Delayed Price · Currency is KRW | Market Cap | 32.48B -3.4% |
| Revenue (ttm) | 5.47B -0.2% |
| Net Income | -1.14B |
| EPS | -280.23 |
| Shares Out | 5.97M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (1.84%) |
| Ex-Dividend Date | n/a |
| Volume | 9,325 |
| Open | 5,850.00 |
| Previous Close | 5,700.00 |
| Day's Range | 5,410.00 - 5,860.00 |
| 52-Week Range | 4,375.00 - 8,460.00 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Wooyang P&L
Wooyang P&L Co.,Ltd. operates multiplex movie theaters under the name of Daehan Theatre in South Korea. The company operates through Theater, Petroleum Sales, and Cultural Leisure segments. It also engages in gas station, cafe, and bakery operations. In addition, the company operates Daehan theatre with 11 screens. The company was formerly known as The Century Co., Ltd. and changed its name to Wooyang P&L Co.,Ltd. in August 2026. The Century Co., Ltd. was founded in 1958 and is based in Seoul, South Korea. [Read more]
News
Century Aluminum Shares Climb Over 5% as Alcoa Earnings Beat and Tight Aluminum Supply Lift US Producers
Century Aluminum shares rose 5.6% after stronger-than-expected Alcoa earnings and historically low global aluminium inventories boosted sentiment towards US producers ahead of Century's quarterly resu...
Bank7 (BSVN) Q3 2026 Earnings Call Transcript
Century acquisition closing Nov. 1 positions bank for margin expansion and cost savings.
Zacks Industry Outlook PulteGroup, M/I Homes and Century
PulteGroup, M/I Homes and Century have been highlighted in this Industry Outlook article.
Lennox Signs Deal To Buy Heat Controller
(RTTNews) - U.S. heating and cooling equipment maker Lennox International Inc (LII) announced on Thursday that it has signed a definitive agreement to acquire HVAC equipment supplier Heat Controller, ...
Century (CCS) Q1 2026 Earnings Call Transcript
Century (CCS) Q1 2026 Earnings Call Transcript
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support ant...
Insider Selling: Matt Aboud Unloads $793K Of Century Aluminum Stock
Matt Aboud , SVP at Century Aluminum (NASDAQ: CENX), disclosed an insider sell on March 4, according to a recent SEC filing. What Happened: Aboud's recent Form 4 filing with the U.S. Securities and E...
EVP At Century Aluminum Sells $3.35M Of Stock
Revealing a significant insider sell on February 25, John DeZee , EVP at Century Aluminum (NASDAQ: CENX), as per the latest SEC filing. What Happened: According to a Form 4 filing with the U.S. Secur...
Calvin Tomkins’s Century
The writer, who has been contributing to The New Yorker since 1958, has chronicled turning a hundred in the same year as the magazine’s centennial.
Sell Alert: GLENCORE INTERNATIONAL AG Cashes Out $272.25M In Century Aluminum Stock
Disclosed on November 13, GLENCORE INTERNATIONAL AG , 10% Owner at Century Aluminum (NASDAQ: CENX), executed a substantial insider sell as per the latest SEC filing. What Happened: AG's recent Form 4...
Friedman Stock Declines Despite Strong Q2 Earnings and Century Deal
FRD reports record second-quarter fiscal 2026 sales and stronger earnings driven by flat-roll growth and the Century Metals acquisition.
Why Century Aluminum Stock Soared Higher Today
Century's Q3 earnings were either very bad or very good -- it depends entirely on how you decide to look at it.
Recent Price Trend in Century (CENX) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Century (CENX) could be a great choice. It is one of the several stocks that passed through our "Recent Price S...
Introducing Century, Toyota’s new car brand that will offer even more luxury than Lexus
For years, the Toyota Century was a car reserved for Japan's elite. Now, Akio Toyoda wants it to represent a new global brand above Lexus.
Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies f...
Insider Decision: Agust F Hafberg Offloads $264K Worth Of Century Aluminum Stock
On September 30, a recent SEC filing unveiled that Agust F Hafberg , SVP & Chief Commercial Officer at Century Aluminum (NASDAQ: CENX) made an insider sell. What Happened: Hafberg's decision to sell ...
Century (CENX) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Century (CENX) could be a great choice. It is one of the several stocks that passed through our "Recent Price S...
Sell Alert: Kenneth L Calloway Cashes Out $452K In Century Aluminum Stock
On September 23, a recent SEC filing unveiled that Kenneth L Calloway , SVP at Century Aluminum (NASDAQ: CENX) made an insider sell. What Happened: Calloway's recent move involves selling 16,450 shar...
Earnings Estimates Rising for Century (CENX): Will It Gain?
Century Aluminum (CENX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Century (CENX) Moves 6.4% Higher: Will This Strength Last?
Century (CENX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Century Aluminum SVP Trades $279K In Company Stock
Revealing a significant insider sell on August 14, Matt Aboud , SVP at Century Aluminum (NASDAQ: CENX), as per the latest SEC filing. What Happened: After conducting a thorough analysis, Aboud sold 1...
Century Reports Flat Loss in Fiscal Q2
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Ital...
Insider Unloading: Jesse E Gary Sells $1.48M Worth Of Century Aluminum Shares
Disclosed on December 30, Jesse E Gary , President and CEO at Century Aluminum (NASDAQ: CENX), executed a substantial insider sell as per the latest SEC filing. What Happened: A Form 4 filing from th...